Sign In
Buy TXG
$31.75
-0.470 (-1.46%)
At Close: Jun 16, 2026
Why 10x Genomics Stock Was Sliding This Week
07:41am, Friday, 23'rd May 2025
Gene sequencing technology company 10x Genomics (TXG 2.52%) hasn't been having it easy in the past few days on the stock market. A bearish analyst move dampened sentiment on the company, and according
10x Genomics (TXG) Upgraded to Buy: Here's What You Should Know
01:06pm, Wednesday, 21'st May 2025
10x Genomics (TXG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Torex Gold Reports Latest Drilling Results from ELG Underground
06:00pm, Tuesday, 20'th May 2025
Results continue to indicate high-grade mineralization and the long-term potential of the deposit (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - Ma
10x Genomics Announces Patent Litigation Settlement Agreement with Bruker
04:05pm, Wednesday, 14'th May 2025
PLEASANTON, Calif. , May 14, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has reached a settlement agreement with Bruk
Wall Street Analysts Believe 10x Genomics (TXG) Could Rally 55.85%: Here's is How to Trade
11:00am, Tuesday, 13'th May 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 55.9% in 10x Genomics (TXG). While the effectiveness of this highly sought-after metric is questionable, the po
10x Genomics, Inc. (TXG) Q1 2025 Earnings Call Transcript
09:34pm, Thursday, 08'th May 2025
10x Genomics, Inc. (NASDAQ:TXG ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Cassie Corneau – Senior Director, Investor Relations Serge Saxonov – Chief Executive O
Compared to Estimates, 10x Genomics (TXG) Q1 Earnings: A Look at Key Metrics
08:00pm, Thursday, 08'th May 2025
Although the revenue and EPS for 10x Genomics (TXG) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Str
10x Genomics (TXG) Reports Q1 Loss, Tops Revenue Estimates
06:56pm, Thursday, 08'th May 2025
10x Genomics (TXG) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to loss of $0.50 per share a year ago.
10x Genomics Reports First Quarter 2025 Financial Results
04:05pm, Thursday, 08'th May 2025
PLEASANTON, Calif. , May 8, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter ended March 31,
Torex Gold Reports Q1 2025 Results
06:00pm, Wednesday, 07'th May 2025
Results in line with expectations and tracking well to full-year guidance (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - May 7, 2025) - Torex Gold
Torex Gold Declares Commercial Production at Media Luna
06:00pm, Thursday, 01'st May 2025
Milestone marks the Company's official transition to become both a gold and copper producer (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - May 1, 2
10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
11:08am, Thursday, 01'st May 2025
10x Genomics (TXG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
10x Genomics to Participate in the BofA Securities 2025 Healthcare Conference
04:05pm, Wednesday, 30'th Apr 2025
PLEASANTON, Calif. , April 30, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate
Torex Gold Reports Q1 2025 Production Results
06:00pm, Thursday, 10'th Apr 2025
Processing plant tie-ins concluded and first copper concentrate achieved; quarterly production in line with plan (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(News
Vizgen Announces End of Litigation with 10x Genomics and Harvard University
08:00am, Thursday, 03'rd Apr 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- #neuroscience--Vizgen, Inc., the life sciences company revolutionizing spatial genomics research and driving innovation in spatial multi-omics, today released an op
